Stemedica and Scripps to Jointly Investigate Therapeutic Effect of…

Stemedica Cell Technologies, Inc., a leading manufacturer of adult ischemia tolerant allogeneic stem cells and stem cell factors announced that the Company has signed an agreement with The Scripps…

(PRWeb December 21, 2012)

Read the full story at http://www.prweb.com/releases/stemedica-scripps-ards/stem-cell-factors-sepsis/prweb10263983.htm


Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!